{"id":988022,"date":"2020-06-06T18:10:52","date_gmt":"2020-06-06T11:10:52","guid":{"rendered":"https:\/\/enormacdigital.com\/inno.n\/research-areas\/"},"modified":"2023-06-23T13:47:26","modified_gmt":"2023-06-23T06:47:26","slug":"research-areas","status":"publish","type":"page","link":"https:\/\/kolmar.vn\/ko\/research-areas\/","title":{"rendered":"Research Areas"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h1>\n\tResearch Areas\n\t<\/h1>\n\t<p>Aiming to be recognized as a global pharmaceutical drug developer<\/p>\n\tResearch Areas<h2>\n\tinno.N&#8217;s R&amp;D\n\t<\/h2>\n\t<p>Through continuous innovation and aggressive R&amp;D, inno.N re-writes the history of rising to the challenge. While upgrading its pipeline with competitive candidate drugs for the circulatory system, metabolic system, the gastrointestinal system as well as IV products, inno.N also invests heavily in the research and development of new drugs for gastrointestinal diseases, immune diseases, infections and vaccines.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" width=\"575\" height=\"400\" src=\"https:\/\/enormacdigital.com\/inno.n\/wp-content\/uploads\/2023\/01\/lab01.png\" alt=\"lab01\" itemprop=\"image\" title=\"lab01\" onerror=\"this.style.display='none'\"  sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/01\/lab01.png 575w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/01\/lab01-466x324.png 466w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/01\/lab01-350x243.png 350w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tNovel Drug Research Center\n\t<\/h3>\n\t<p>Based on its extensive experience in drug development, inno.N has successfully launched a new product called &#8216;K-CAB Tab.&#8217;, A treatment for gastroesophageal reflux disease in Korea. inno.N is gradually expanding its market by focusing on gastrointestinal, cancer and immunological drugs to meet the high demand of the open market. In parallel, inno.N is continuing to implement many projects &#8220;Research &amp; amp; Innovation &#8220;with leading R &amp; amp; D companies in Korea, Japan, the US and Europe to accelerate the development of potential new drugs and expand the R &amp;\u00a0 D network globally.<\/p>\n<h3>\n\tBiology Research Center\n\t<\/h3>\n\t<p>The R&amp;D capabilities that made the commercialization of interferon alpha\/beta, GCSF and EPO possible are now geared towards developing a variety of drugs based on biological mechanisms. Current R&amp;D in the area include second generation protein drugs, differentiated products focusing on antibodies, vaccines, and cell and gene therapy.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" width=\"575\" height=\"400\" src=\"https:\/\/sitetheme.info\/wp-content\/uploads\/2023\/02\/lab02.png\" alt=\"lab02\" itemprop=\"image\" title=\"lab02\" onerror=\"this.style.display='none'\"  sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab02.png 575w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab02-466x324.png 466w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab02-350x243.png 350w\" \/>\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" width=\"575\" height=\"400\" src=\"https:\/\/sitetheme.info\/wp-content\/uploads\/2023\/02\/lab03.png\" alt=\"lab03\" itemprop=\"image\" title=\"lab03\" onerror=\"this.style.display='none'\"  sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab03.png 575w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab03-466x324.png 466w, https:\/\/inno-n.vn\/wp-content\/uploads\/2023\/02\/lab03-350x243.png 350w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tHealth and Beauty Research Center\n\t<\/h3>\n\t<p>Drawing on its experience of having conducted research and development on Condition and Oriental Raisin water, both of which are perennial steady-sellers, the Institute has been focusing on the development of materials and ingredients that can be individually recognized for their efficacy in treating chronic diseases and age-related medical conditions, in addition to branded blockbuster consumer goods offering new health benefits.<\/p>\n<h2>\n\tR&amp;D strategies\n\t<\/h2>\n<h2>\n\tR&amp;D investment\n\t<\/h2>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Research Areas Aiming to be recognized as a global pharmaceutical drug developer Research Areas inno.N&#8217;s R&amp;D Through continuous innovation and aggressive R&amp;D, inno.N re-writes the history of rising to the challenge. While upgrading its pipeline with competitive candidate drugs for the circulatory system, metabolic system, the gastrointestinal system as well as IV products, inno.N also&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"_links":{"self":[{"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/pages\/988022"}],"collection":[{"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/comments?post=988022"}],"version-history":[{"count":5,"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/pages\/988022\/revisions"}],"predecessor-version":[{"id":990264,"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/pages\/988022\/revisions\/990264"}],"wp:attachment":[{"href":"https:\/\/kolmar.vn\/ko\/wp-json\/wp\/v2\/media?parent=988022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}